CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Precision Spectra™ SCS system programming featuresdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02492880
NCT02492880N/ACompleted
CompareCT.gov

Study to Characterize the Effects of Programming Features of the Boston Scientific Precision Spectra™ Spinal Cord Stimulator System Using the CoverEdge™ Surgical Leads

Boston Scientific Corporation·interventional·Posted Jul 9, 2015·Updated Nov 4, 2022

In Brief

A clinical study evaluating Precision Spectra™ SCS system programming features for Chronic Pain. Completed, enrolled 15 participants across 2 sites.

Detailed Summary

This is a prospective, on-label, multi-center, non-randomized, exploratory, single-arm study to characterize the effects of programming features of the Boston Scientific Precision Spectra™ Spinal Cord Stimulator (SCS) System using the CoverEdge™ surgical lead.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 9, 2015
Enrollment StartJul 20, 2015
Primary CompletionFeb 21, 2017
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.0 years ago

Interventions

Precision Spectra™ SCS system programming featuresdevice

Precision Spectra™ SCS system programming features using the CoverEdge surgical lead.